March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms.

Konica Minolta's Exa Platform

Picture archiving and communication systems (PACS) play a crucial role in modern radiology by providing a digital platform for the storage, retrieval, distribution and presentation of medical images. A PACS acts as a computer network for digitized radiological images and reports.
Hal Wolf, president and CEO of HIMSS

Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition was particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare and a quality experience for those in this demanding, rapidly evolving industry.

March 5, 2024 — GE HealthCare announced its latest innovation in ultrasound with the launch of its next-level LOGIQ ultrasound portfolio—including the new LOGIQ Totus—highlighting the company’s progress in advancing precision care.

March 5, 2024 — Life Guard Imaging, a pioneering leader in preventative imaging services, is thrilled to announce its new sponsorship collaboration with the iconic Major League Baseball organization, the 

A look at ITN's top-viewed content for February 2024

As February ends and we welcome in Spring, ITN takes a look at last month's Top 10.

1. Philips Recalls BrightView Imaging Systems Due to the Detector Unexpectedly Falling

2. VIDEO: Talking Trends with Philips: Improving Operational Efficiency, Enhancing Patient Care Via the Cloud

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software solutions company 

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI)-based tomosynthesis X-ray imaging system, has reported that its team, which began clinical trials in late 2023, is very pleased with the early ARC60 imaging results, both in terms of depiction of details and consistency of imaging quality.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now